sentence1
stringlengths
1.08k
96.5k
sentence2
stringlengths
51
966
labels
stringclasses
3 values
metadata
stringlengths
123
2.56k
Background This study aimed to assess the effects of a risk-based, multifactorial fall prevention programme on health-related quality of life among the community-dwelling aged who had fallen at least once during the previous 12 months. Methods The study is a part of a single-centre, risk-based, multifactorial rand...
Intervention: multifactorial fall prevention programme intervention group (IG) Comparator: control group (CG) Outcome: usual activities among women
1
{"evidence_spans": [{"end": 1442, "start": 1293, "text": "0.051). In women, significant differences in the changes between the groups were found in usual activities (p = 0.005) and discomfort/symptoms (p = 0"}, {"end": 16117, "start": 15901, "text": "tivity (p = 0.051) among men (additional file 2). In women, the analy...
Aim To assess the effects of a functional and individualised exercise programme on gait biomechanics during walking in people with knee OA. Methods Sixty participants were randomised to 12 weeks of facility-based functional and individualised neuromuscular exercise therapy (ET), 3 sessions per week supervised by t...
Intervention: neuromuscular exercise therapy (ET) Comparator: no attention control group (CG) Outcome: second peak knee flexor moment
-1
{"evidence_spans": [{"end": 16397, "start": 16167, "text": "\r\nIn the CG one participant had invalid gait analysis at baseline and one at follow-up, four were lost to follow-up, and there was one protocol violation; a man in the control group disclosed participation in exercise outside the "}], "id": "13053", "pmcid":...
Aim To assess the effects of a functional and individualised exercise programme on gait biomechanics during walking in people with knee OA. Methods Sixty participants were randomised to 12 weeks of facility-based functional and individualised neuromuscular exercise therapy (ET), 3 sessions per week supervised by t...
Intervention: neuromuscular exercise therapy (ET) Comparator: no attention control group (CG) Outcome: second peak vertical ground reaction force
1
{"evidence_spans": [{"end": 21671, "start": 21567, "text": "Step length, m\r\n\u22120.02 (\u22120.07 to 0.02)\r\n\u22120.01 (\u22120.06 to 0.03)\r\n\u22120.01 (\u22120.07 to 0.05)\r\n0.74\r\nCadence, step"}], "id": "13054", "pmcid": "5569270", "prompt_id": "13054", "split_group_id": "5569270", "votes": {"1": 2}}
Background: The aim of this study was to investigate the efficacy of lidocaine solution in the cuff of the endotracheal tube in reducing mucosal damage following tracheal intubation. Materials and Methods: This was a randomized controlled trial study undertaken in the intensive care unit patients. Participants, wh...
Intervention: lidocaine or air was used to fill the tracheal tube cuff Comparator: air group Outcome: The mean arterial blood pressure
0
{"evidence_spans": [{"end": 9504, "start": 9397, "text": "tiology of ICU hospitalization (P = 0.15). The mean arterial blood pressure was not statistically significa"}], "id": "13055", "pmcid": "3872578", "prompt_id": "13055", "split_group_id": "3872578", "votes": {"0": 2}}
Background: The aim of this study was to investigate the efficacy of lidocaine solution in the cuff of the endotracheal tube in reducing mucosal damage following tracheal intubation. Materials and Methods: This was a randomized controlled trial study undertaken in the intensive care unit patients. Participants, wh...
Intervention: lidocaine or air was used to fill the tracheal tube cuff Comparator: air group Outcome: oxygen saturation
0
{"evidence_spans": [{"end": 9772, "start": 9635, "text": "at the tracheal tube during the intubation. Consequently, oxygen saturation was not statistically significant different between lidocaine"}, {"end": 9771, "start": 9648, "text": "al tube during the intubation. Consequently, oxygen saturation was not statisticall...
Background: Insulin resistance is a measure of metabolic stress in the perioperative period. Before now, no clinical trial has determined the summative effects of glutamine, L-carnitine, and antioxidants as metabolic conditioning supplements in the perioperative period. Objectives: The purpose of this study was to...
Intervention: 4) PP: placebo before and after the surgery; Comparator: 3) SS: supplement before and after the surgery; SP (supplement/placebo): supplement seven days before and placebo 30 days after the surgery; 2) PS: placebo before and supplement after the surgery; Outcome: Blood glucose level
1
{"evidence_spans": [{"end": 1893, "start": 1688, "text": "Results:\r\nBlood glucose levels were increased postoperatively in the four groups (< 0.001), but a significantly higher increase occurred in the PP group compared to the SP (0.027), PS (0.026), and SS (0.00"}], "id": "13058", "pmcid": "4752820", "prompt_id": "1...
Background: Insulin resistance is a measure of metabolic stress in the perioperative period. Before now, no clinical trial has determined the summative effects of glutamine, L-carnitine, and antioxidants as metabolic conditioning supplements in the perioperative period. Objectives: The purpose of this study was to...
Intervention: 4) PP: placebo before and after the surgery; Comparator: 3) SS: supplement before and after the surgery; SP (supplement/placebo): supplement seven days before and placebo 30 days after the surgery; 2) PS: placebo before and supplement after the surgery; Outcome: superficial wound infection rate
1
{"evidence_spans": [{"end": 2045, "start": 1894, "text": ") groups. The superficial wound infection rate was significantly different between the four groups (0.021): 26.08% in PP, 9.09% in SP, 4.54% in PS, and"}], "id": "13059", "pmcid": "4752820", "prompt_id": "13059", "split_group_id": "4752820", "votes": {"1": 2}}
This study evaluated the efficacy and safety of adding etanercept to disease-modifying antirheumatic drugs (DMARDs) in patients with moderately active rheumatoid arthritis (RA). This randomized, double-blind, placebo-controlled study (ClinicalTrials.gov #NCT01313208) enrolled RA patients with Disease Activity Score usi...
Intervention: etanercept 50&nbsp;mg Comparator: placebo Outcome: low disease activity (LDA)
0
{"evidence_spans": [{"end": 1188, "start": 1050, "text": " At week 12, 33% on etanercept and 21% on placebo achieved LDA (P\u2009=\u20090.055); remission was achieved in 19% and 12%, respectively (P\u2009=\u20090.14)"}, {"end": 1704, "start": 1531, "text": "LDA was achieved by more patients on etanercept than placebo i...
Background Preventing children from smoking is a public health priority. This study evaluated the effects of a sport-for-health smoking prevention programme (SmokeFree Sports) on smoking-related intentions and cognitions among primary school children from deprived communities. Methods A non-randomised-controlled t...
Intervention: sport-for-health smoking prevention programme (SmokeFree Sports) Comparator: usual smoking education only Outcome: non-smoking intentions, for cigarette refusal self-efficacy
0
{"evidence_spans": [{"end": 1271, "start": 992, "text": "lyses. There were no significant differences between the two study groups for non-smoking intentions (T1: \u03b2\u2009=\u20090.02, 95\u00a0% CI\u2009=\u2009-0.08\u20130.12; T2: \u03b2\u2009=\u20090.08, 95\u00a0% CI\u2009=\u2009-0.02\u20130.17) or for cigarette re...
Background Preventing children from smoking is a public health priority. This study evaluated the effects of a sport-for-health smoking prevention programme (SmokeFree Sports) on smoking-related intentions and cognitions among primary school children from deprived communities. Methods A non-randomised-controlled t...
Intervention: sport-for-health smoking prevention programme (SmokeFree Sports) Comparator: usual smoking education only Outcome: ‘definitely’ believing that: ‘it is not safe to smoke for a year or two as long as you quit after that’ , ‘it is difficult to quit smoking once started’ , ‘smoke from other peoples’ cigarette...
1
{"evidence_spans": [{"end": 32476, "start": 31923, "text": "sical activity and mother/father/sibling/friend smoking\r\n\r\nd\u03b2 value\r\n\r\neRelative risk\r\n\r\n\r\nCigarette refusal self-efficacy\r\nThe adjusted multilevel linear regression analyses showed no significant intervention effects between baseline and ...
ABSTRACT Objective: To compare our previously published new minimally access hydrocelectomy versus Jaboulay's procedure regarding operative outcome and patient's satisfaction. Materials and Methods: A total of 124 adult patients were divided into two groups: A and B. Group A patients were subjected to conventiona...
Intervention: Group A patients - conventional surgical hydrocelectomy (Jaboulay's procedure) Comparator: group B - the new minimal access hydrocelectomy Outcome: The mean time off from work
1
{"evidence_spans": [{"end": 11362, "start": 11269, "text": "ys in group B while in group A was 12.5\u00b13.53 (10\u201315) days. The mean time off from work in gro"}, {"end": 11371, "start": 11269, "text": "ys in group B while in group A was 12.5\u00b13.53 (10\u201315) days. The mean time off from work in group B was "...
ABSTRACT Objective: To compare our previously published new minimally access hydrocelectomy versus Jaboulay's procedure regarding operative outcome and patient's satisfaction. Materials and Methods: A total of 124 adult patients were divided into two groups: A and B. Group A patients were subjected to conventiona...
Intervention: Group A patients - conventional surgical hydrocelectomy (Jaboulay's procedure) Comparator: group B - the new minimal access hydrocelectomy Outcome: The operative time
1
{"evidence_spans": [{"end": 857, "start": 754, "text": "sults:\r\nThe mean operative time in group B was 15.1\u00b14.24 minutes and in group A was 32.5\u00b14.76 minutes ("}, {"end": 10751, "start": 10540, "text": " by the health organization of the company they work for.\r\nThe operative time in group B ranged between...
ABSTRACT Objective: To compare our previously published new minimally access hydrocelectomy versus Jaboulay's procedure regarding operative outcome and patient's satisfaction. Materials and Methods: A total of 124 adult patients were divided into two groups: A and B. Group A patients were subjected to conventiona...
Intervention: Group A patients - conventional surgical hydrocelectomy (Jaboulay's procedure) Comparator: group B - the new minimal access hydrocelectomy Outcome: The mean time of hospital stay
0
{"evidence_spans": [{"end": 11025, "start": 10752, "text": " 32.5\u00b14.76 minutes with significant distribution (P\u22640.02). The mean time of hospital stay for group B was 13.48\u00b16.38 hours with 10 hours as a minimum and 30 hours as a maximum value, while in group A was 21.19\u00b111.65 hours with 12 hours as a...
High-dose intravenous immunoglobulin (IVIG) therapy has been effective in treating various autoimmune and systemic inflammatory diseases. Here, we assessed the efficacy and safety of IVIG therapy with polyethylene glycol-treated human IgG (drug code GB-0998) for patients with corticosteroid-refractory polymyositis (PM)...
Intervention: polyethylene glycol-treated human IgG (drug code GB-0998) Comparator: placebo Outcome: The median times until improvement
0
{"evidence_spans": [{"end": 20700, "start": 20488, "text": "ce was not statistically significant.\r\n\r\nTime to improvement in MMT score\r\nThe time (number of days) until the improvement in the MMT score reached 5 or more was compared between the two groups.\r\nThe Kaplan\u2013Meier"}, {"end": 20706, "start": 20488, ...
High-dose intravenous immunoglobulin (IVIG) therapy has been effective in treating various autoimmune and systemic inflammatory diseases. Here, we assessed the efficacy and safety of IVIG therapy with polyethylene glycol-treated human IgG (drug code GB-0998) for patients with corticosteroid-refractory polymyositis (PM)...
Intervention: polyethylene glycol-treated human IgG (drug code GB-0998) Comparator: placebo Outcome: The median time until normalization of the serum CK level
-1
{"evidence_spans": [{"end": 21631, "start": 21415, "text": "d, the test was discontinued on day\u00a056\r\n\r\n\r\nTime until normalization of serum CK level\r\nThe Kaplan\u2013Meier survival curves for time (number of days) until the first normalization of serum CK level after initiation of s"}, {"end": 21632, "start"...
High-dose intravenous immunoglobulin (IVIG) therapy has been effective in treating various autoimmune and systemic inflammatory diseases. Here, we assessed the efficacy and safety of IVIG therapy with polyethylene glycol-treated human IgG (drug code GB-0998) for patients with corticosteroid-refractory polymyositis (PM)...
Intervention: polyethylene glycol-treated human IgG (drug code GB-0998) Comparator: placebo Outcome: swallowing action
1
{"evidence_spans": [{"end": 27205, "start": 26917, "text": "ges of ADL scores for the 15 actions evaluated in this study, during the first period, are shown in Fig.\u00a08. The point-estimation values show that the changes were greater in the GB-0998 group than in the placebo group for 12 of the 15 actions, although th...
High-dose intravenous immunoglobulin (IVIG) therapy has been effective in treating various autoimmune and systemic inflammatory diseases. Here, we assessed the efficacy and safety of IVIG therapy with polyethylene glycol-treated human IgG (drug code GB-0998) for patients with corticosteroid-refractory polymyositis (PM)...
Intervention: polyethylene glycol-treated human IgG (drug code GB-0998) Comparator: placebo Outcome: Dysphagia
0
{"evidence_spans": [{"end": 27930, "start": 27497, "text": "0222).Fig.\u00a08Forest plots of before\u2013after differences in ADL scores for the 8-week first period. Black circles and lines, respectively, represent point estimates and 95% confidence intervals of between-group differences (GB-0998 group versus placebo g...
Background/Aims Endoscopic submucosal dissection (ESD) is accepted as a treatment for gastric neoplasms and usually requires deep sedation. The aim of this study was to evaluate the safety and efficacy profiles of deep sedation induced by continuous propofol infusion with or without midazolam during ESD. Methods A...
Intervention: the propofol group Comparator: the combination group (propofol plus midazolam) Outcome: The average specimen size
-1
{"evidence_spans": [{"end": 10700, "start": 10579, "text": "third of the stomach in both groups. The average specimen size was 34.74\u00b113.65 mm in the propofol group and 42.74\u00b116.86 m"}], "id": "13076", "pmcid": "3493727", "prompt_id": "13076", "split_group_id": "3493727", "votes": {"-1": 2}}
Background/Aims Endoscopic submucosal dissection (ESD) is accepted as a treatment for gastric neoplasms and usually requires deep sedation. The aim of this study was to evaluate the safety and efficacy profiles of deep sedation induced by continuous propofol infusion with or without midazolam during ESD. Methods A...
Intervention: the propofol group Comparator: the combination group (propofol plus midazolam) Outcome: the mean procedure time
0
{"evidence_spans": [{"end": 10835, "start": 10701, "text": " in the combination group (p=0.003).\r\nTable 3 shows that the mean procedure time was not significantly different between the two group"}], "id": "13077", "pmcid": "3493727", "prompt_id": "13077", "split_group_id": "3493727", "votes": {"0": 2}}
Background/Aims Endoscopic submucosal dissection (ESD) is accepted as a treatment for gastric neoplasms and usually requires deep sedation. The aim of this study was to evaluate the safety and efficacy profiles of deep sedation induced by continuous propofol infusion with or without midazolam during ESD. Methods A...
Intervention: the propofol group Comparator: the combination group (propofol plus midazolam) Outcome: The mean propofol infusion rate
1
{"evidence_spans": [{"end": 11103, "start": 10980, "text": " (378\u00b1220 mg vs 466\u00b1200 mg, p=0.012). The mean propofol infusion rate was lower in the combination group (0.118\u00b10.03 mg/kg/"}], "id": "13078", "pmcid": "3493727", "prompt_id": "13078", "split_group_id": "3493727", "votes": {"1": 2}}
Background/Aims Endoscopic submucosal dissection (ESD) is accepted as a treatment for gastric neoplasms and usually requires deep sedation. The aim of this study was to evaluate the safety and efficacy profiles of deep sedation induced by continuous propofol infusion with or without midazolam during ESD. Methods A...
Intervention: the propofol group Comparator: the combination group (propofol plus midazolam) Outcome: mean recovery time
-1
{"evidence_spans": [{"end": 959, "start": 896, "text": "12), a longer mean recovery time (10.5 minutes vs 7.9 minutes, "}, {"end": 11220, "start": 11104, "text": "in vs 0.160\u00b10.06 mg/kg/min, p<0.001), but the combination group had a longer mean recovery time (7.9\u00b13.78 minutes vs"}], "id": "13079", "pmcid": "3...
Background/Aims Endoscopic submucosal dissection (ESD) is accepted as a treatment for gastric neoplasms and usually requires deep sedation. The aim of this study was to evaluate the safety and efficacy profiles of deep sedation induced by continuous propofol infusion with or without midazolam during ESD. Methods A...
Intervention: the propofol group Comparator: the combination group (propofol plus midazolam) Outcome: mild hypoxemia
0
{"evidence_spans": [{"end": 11486, "start": 11381, "text": "e adverse events are shown in Table 4. There were three cases of mild hypoxemia in the propofol group and"}], "id": "13080", "pmcid": "3493727", "prompt_id": "13080", "split_group_id": "3493727", "votes": {"0": 2}}
Pomegranate has been shown to prolong PSA doubling time in early prostate cancer, but no data from a placebo controlled trial has been published yet. The objective of this study was to prospectively evaluate the impact of pomegranate juice in patients with prostate cancer. We conducted a phase IIb, double blinded, ran...
Intervention: 500 ml of pomegranate juice Comparator: 500 ml of placebo Outcome: tumor size
1
{"evidence_spans": [{"end": 12372, "start": 12254, "text": "ery or irradiation while on study. Statistically significant differences in tumor size (T3; 31% in the control vs. 51%"}], "id": "13081", "pmcid": "3781990", "prompt_id": "13081", "split_group_id": "3781990", "votes": {"1": 1}}
Pomegranate has been shown to prolong PSA doubling time in early prostate cancer, but no data from a placebo controlled trial has been published yet. The objective of this study was to prospectively evaluate the impact of pomegranate juice in patients with prostate cancer. We conducted a phase IIb, double blinded, ran...
Intervention: 500 ml of pomegranate juice Comparator: 500 ml of placebo Outcome: PSA progression
0
{"evidence_spans": [{"end": 13938, "start": 13803, "text": "nificant between the two arms (table 2). PSA progression within the first four weeks was observed in 41% in the control group compared "}], "id": "13083", "pmcid": "3781990", "prompt_id": "13083", "split_group_id": "3781990", "votes": {"0": 2}}
Pomegranate has been shown to prolong PSA doubling time in early prostate cancer, but no data from a placebo controlled trial has been published yet. The objective of this study was to prospectively evaluate the impact of pomegranate juice in patients with prostate cancer. We conducted a phase IIb, double blinded, ran...
Intervention: 500 ml of pomegranate juice Comparator: 500 ml of placebo Outcome: pain
0
{"evidence_spans": [{"end": 1415, "start": 1319, "text": ". No differences were detected between the two groups with regard to PSA kinetics and pain score"}, {"end": 15467, "start": 15314, "text": "ients that had been under PJ continuously. The patients reported pain values in the range from 0-5 at study entry without ...
Background High miR-31-3p expression is associated with inferior outcomes in KRAS wild-type (WT) advanced colorectal cancer patients treated with anti-EGFR therapy. This study evaluated miR-31-3p expression in patients with operable colorectal liver metastases (LM) enrolled in the New EPOC study. Methods MiR-31-3p...
Intervention: chemotherapy alone (CT) Comparator: chemotherapy plus cetuximab (CTX) Outcome: The median progression-free survival
-1
{"evidence_spans": [{"end": 882, "start": 670, "text": "sults\r\nThe median progression-free survival for the combined populations with mid or high miR-31-3p expression was shorter in the CTX versus the CT arm (26.7 months versus 12.3 months, HR=2.28 95%CI 1.27; 4.09 p="}], "id": "13085", "pmcid": "5706840", "prompt_id...
Objective We hypothesized that, among parents of potential neonatal research subjects, an accompanying cover sheet added to the permission form (intervention) would increase understanding of the research, when compared to a standard form (control). Study Design This pilot study enrolled parents approached for one ...
Intervention: cover sheet added to the permission form (intervention) Comparator: standard form (control) Outcome: comprehension score , subjective understanding , overall satisfaction with consent
0
{"evidence_spans": [{"end": 897, "start": 664, "text": "ntion). There were no differences in comprehension score (16.8 \u00b1 5.7 v. 16.3 \u00b1 3.5), subjective understanding (median 6.0 v. 6.5), or overall satisfaction with consent (median 7.0 v. 6.5) between control and intervention groups (all "}, {"end": 898, "sta...
Background: Narcotic drugs have been used to attenuate laryngoscopy and intubation induced circulatory responses, but are not always available due to tough narcotics laws. Nalbuphine a synthetic opioid, free from restrictions has been in use for post-operative pain relief. Hence, we decided to compare nalbuphine and p...
Intervention: nalbuphine 0.2 mg/kg Comparator: pentazocine 0.5 mg/kg Outcome: blood pressure (BP)
-1
{"evidence_spans": [{"end": 7958, "start": 7501, "text": "and MAP showed a similar pattern.\r\nIn group N, mean values of BP after an initial decrease until 5 min after the study drug showed a clinically significant rise at IAETI (maximum) and until 3 min thereafter, but fell below the mean basal values at the end of t...
Background: Narcotic drugs have been used to attenuate laryngoscopy and intubation induced circulatory responses, but are not always available due to tough narcotics laws. Nalbuphine a synthetic opioid, free from restrictions has been in use for post-operative pain relief. Hence, we decided to compare nalbuphine and p...
Intervention: nalbuphine 0.2 mg/kg Comparator: pentazocine 0.5 mg/kg Outcome: Rate pressure product (RPP)
-1
{"evidence_spans": [{"end": 1653, "start": 1404, "text": "zocine. Maximum rise in both the group was observed immediately after larygoscopy and intubation and these started to return toward the basal values at the end of the study period, but remained above the initial values. (pentazocine > nalbuphine P ="}, {"end": 8...
Abstract Background and aims: Recent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate–midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propo...
Intervention: etomidate Comparator: propofol based on midazolam Outcome: induction time, total procedure time and awake time
0
{"evidence_spans": [{"end": 12240, "start": 12103, "text": "\u200a.930), and epinephrine injection (P\u200a=\u200a.934). Sedation-related outcomes such as induction time (P\u200a=\u200a.833), total procedure time (P\u200a=\u200a.111"}, {"end": 12252, "start": 12104, "text": ".930), and epinephrine injection (P\u200a=\u...
Abstract Background and aims: Recent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate–midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propo...
Intervention: etomidate Comparator: propofol based on midazolam Outcome: The incidence rate of all cardiopulmonary adverse events
-1
{"evidence_spans": [{"end": 965, "start": 830, "text": "ults:\r\nThe incidence of cardiopulmonary adverse events was higher in the propofol group (72.6%) than in the etomidate group (54.8%) (P\u200a"}, {"end": 12617, "start": 12449, "text": "n-related outcomes.\r\n\r\n3.2Safety-related outcomes\r\nThe incidence rate of...
Abstract Background and aims: Recent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate–midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propo...
Intervention: etomidate Comparator: propofol based on midazolam Outcome: The incidence rate of vital sign fluctuation (VSF)
-1
{"evidence_spans": [{"end": 1082, "start": 965, "text": "=\u200a.040). VSF was detected in 17 (27.4%) and 31 (50.0%) patients in the etomidate and propofol groups, respectively (P"}, {"end": 12877, "start": 12749, "text": "tion, permanent neurological impairment, and death. The incidence rate of VSF was significantly h...
Abstract Background and aims: Recent studies have shown that etomidate is associated with fewer serious adverse events than propofol and has a noninferior sedative effect. We investigated whether etomidate–midazolam is associated with fewer cardiopulmonary adverse events and has noninferior efficacy compared to propo...
Intervention: etomidate Comparator: propofol based on midazolam Outcome: The incidence rate of myoclonus
1
{"evidence_spans": [{"end": 1391, "start": 1258, "text": "reover, the incidence rate of myoclonus was significantly higher in the etomidate group (16.1%) than in the propofol group (1.6%) (P\u200a"}, {"end": 13359, "start": 13216, "text": ".8%) than in the propofol group (8.1%) (P\u200a=\u200a.008). The incidence rate ...
Objectives We reviewed testosterone changes for patients who were treated with radiation therapy (RT) alone on NRG oncology RTOG 9408. Methods and materials Patients (T1b-T2b, prostate-specific antigen <20 ng/mL) were randomized between RT alone and RT plus 4 months of androgen ablation. Serum testosterone (ST) le...
Intervention: PORT, prostate-only radiation therapy Comparator: WPRT, whole-pelvis radiation therapy Outcome: Serum testosterone (ST)
0
{"evidence_spans": [{"end": 10555, "start": 10379, "text": "of patients who were treated with PORT and completed RT and who had no prior hormonal therapy, the median change in ST was \u221211.0\u2009ng/dL (n\u2009=\u200961) at the end of RT (P\u2009=\u2009.13) and \u2212"}], "id": "13102", "pmcid": "5707413", "prompt_i...
A randomized controlled trial showing that a bupivacaine lozenge provided clinically significant pain relief in head and neck cancer patients with radiotherapy-related oral mucositis. Abstract Introduction: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated...
Intervention: Lozenge group Comparator: Control group Outcome: Mean pain
-1
{"evidence_spans": [{"end": 18703, "start": 18542, "text": "up, showed a significant difference between groups in favor of the lozenge. Mean pain was 35 mm in patients in the Lozenge group and 51 mm in patients in the Con"}, {"end": 18725, "start": 18542, "text": "up, showed a significant difference between groups in f...
A randomized controlled trial showing that a bupivacaine lozenge provided clinically significant pain relief in head and neck cancer patients with radiotherapy-related oral mucositis. Abstract Introduction: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated...
Intervention: Lozenge group Comparator: Control group Outcome: intensity of oral cavity pain
-1
{"evidence_spans": [{"end": 19507, "start": 19235, "text": " superior results compared with the Control group (Table 2, Fig. 4, and Fig. 5). When pain for the Lozenge group was measured as the mean pain score 60 minutes after lozenge administration, the intensity of oral cavity pain was significantly lower in the Lozen...
A randomized controlled trial showing that a bupivacaine lozenge provided clinically significant pain relief in head and neck cancer patients with radiotherapy-related oral mucositis. Abstract Introduction: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated...
Intervention: Lozenge group Comparator: Control group Outcome: Pharyngeal mucositis pain
0
{"evidence_spans": [{"end": 19599, "start": 19508, "text": " in the Control group (mean difference: \u221218 mm, 95% CI: \u221227 to \u221210, P = 0.0002). Pharyngeal"}, {"end": 19618, "start": 19508, "text": " in the Control group (mean difference: \u221218 mm, 95% CI: \u221227 to \u221210, P = 0.0002). Pharyngeal muc...
A randomized controlled trial showing that a bupivacaine lozenge provided clinically significant pain relief in head and neck cancer patients with radiotherapy-related oral mucositis. Abstract Introduction: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated...
Intervention: Lozenge group Comparator: Control group Outcome: the mean pain score immediately before the next lozenge
-1
{"evidence_spans": [{"end": 20517, "start": 20164, "text": "2 hours in the Control group (n=16). The error bars show 95% confidence intervals.\r\nWhen pain for the Lozenge group was measured as the mean pain score immediately before the next lozenge, pain was significantly lower in the Lozenge group than in the Control...
Background To determine the effects of probiotic yogurt on performance and health status of young adultfemale endurance swimmers. Methods In a randomized controlled trial, 46 endurance swimmers girls with mean age of 13.8 ±1.8 years,weight of 48.6±7.5kg and height of 159±5.6cm, were studied. Subjects were random...
Intervention: 400 ml probiotic yogurt (intervention group) Comparator: ordinary yogurt (control group) Outcome: Average changes in the records
0
{"evidence_spans": [{"end": 865, "start": 747, "text": "ults\r\n Average changes in the records of the intervention and control groups were 3.9 and 0.5 seconds, respectively(p="}], "id": "13107", "pmcid": "3917487", "prompt_id": "13107", "split_group_id": "3917487", "votes": {"0": 2}}
Background To determine the effects of probiotic yogurt on performance and health status of young adultfemale endurance swimmers. Methods In a randomized controlled trial, 46 endurance swimmers girls with mean age of 13.8 ±1.8 years,weight of 48.6±7.5kg and height of 159±5.6cm, were studied. Subjects were random...
Intervention: 400 ml probiotic yogurt (intervention group) Comparator: ordinary yogurt (control group) Outcome: complained of dyspnea
-1
{"evidence_spans": [{"end": 976, "start": 866, "text": "0.22). The intervention group complained of dyspnea for 2.4 days and the value for the controlwas 4.4 days (p="}, {"end": 1042, "start": 866, "text": "0.22). The intervention group complained of dyspnea for 2.4 days and the value for the controlwas 4.4 days (p=0.0...
Background To determine the effects of probiotic yogurt on performance and health status of young adultfemale endurance swimmers. Methods In a randomized controlled trial, 46 endurance swimmers girls with mean age of 13.8 ±1.8 years,weight of 48.6±7.5kg and height of 159±5.6cm, were studied. Subjects were random...
Intervention: 400 ml probiotic yogurt (intervention group) Comparator: ordinary yogurt (control group) Outcome: Values for ear pain
-1
{"evidence_spans": [{"end": 1042, "start": 977, "text": ".024). Values for ear pain were 0.5 and 1.6 days (p=0.008) respec"}], "id": "13109", "pmcid": "3917487", "prompt_id": "13109", "split_group_id": "3917487", "votes": {"-1": 2}}
Background To determine the effects of probiotic yogurt on performance and health status of young adultfemale endurance swimmers. Methods In a randomized controlled trial, 46 endurance swimmers girls with mean age of 13.8 ±1.8 years,weight of 48.6±7.5kg and height of 159±5.6cm, were studied. Subjects were random...
Intervention: 400 ml probiotic yogurt (intervention group) Comparator: ordinary yogurt (control group) Outcome: The average numberof episodes of respiratory infection
-1
{"evidence_spans": [{"end": 1217, "start": 1043, "text": "ively. The average numberof episodes of respiratory infection in the intervention group was 0.9 day, which was statistically fewer than thatin the control group (1.4 days), P"}], "id": "13110", "pmcid": "3917487", "prompt_id": "13110", "split_group_id": "3917487...
Summary Background Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage. Methods We did an international, randomised placebo-con...
Intervention: 1 g intravenous tranexamic acid bolus followed by an 8 h infusion of 1 g tranexamic acid Comparator: placebo Outcome: proportional odds assumption
0
{"evidence_spans": [{"end": 23431, "start": 23322, "text": "mRS at day 90 after adjustment for stratification and minimisation criteria, with an adjusted odds ratio (aOR"}, {"end": 23649, "start": 23324, "text": "S at day 90 after adjustment for stratification and minimisation criteria, with an adjusted odds ratio (aOR...
Summary Background Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage. Methods We did an international, randomised placebo-con...
Intervention: 1 g intravenous tranexamic acid bolus followed by an 8 h infusion of 1 g tranexamic acid Comparator: placebo Outcome: proportion of participants who were dead or dependent at day 90
0
{"evidence_spans": [{"end": 23649, "start": 23432, "text": " of 0\u00b788 (95% CI 0\u00b776\u20131\u00b703, p=0\u00b711; table 2 and figure 2). A formal goodness-of-fit test showed no evidence that the proportional odds assumption was violated (p=0\u00b797). In a sensitivity analysis, we detected no differ"}, {"end": 2...
Summary Background Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage. Methods We did an international, randomised placebo-con...
Intervention: 1 g intravenous tranexamic acid bolus followed by an 8 h infusion of 1 g tranexamic acid Comparator: placebo Outcome: haematoma expansion at day 2
-1
{"evidence_spans": [{"end": 27741, "start": 27527, "text": "nt effect and time when analysed as a continuous variable (aOR 0\u00b798, 95% CI 0\u00b790\u20131\u00b707, p=0\u00b769).Figure 3Primary outcome by subgroups\r\nAll subgroups were predefined except for intracerebral haemorrhage volume, which "}], "id": "13114",...
Summary Background Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage. Methods We did an international, randomised placebo-con...
Intervention: 1 g intravenous tranexamic acid bolus followed by an 8 h infusion of 1 g tranexamic acid Comparator: placebo Outcome: The mean increase in haematoma volume
-1
{"evidence_spans": [{"end": 27970, "start": 27741, "text": "was added as a post-hoc analysis. OR=odds ratio. NIHSS=National Institutes of Health Stroke Scale.\r\n\r\nFewer participants had haematoma expansion at day 2 in the tranexamic acid group (265 [25%] of 1054 participants) than in the p"}, {"end": 27971, "start":...
This study aimed to explore the effects of open- and closed-skill exercise interventions on the neurocognitive performance of executive functions in the elderly. Sixty-four healthy elderly males were randomly assigned to either a closed-skill (bike riding or brisk walking/jogging, n = 22), open-skill (table tennis, n =...
Intervention: closed-skill (bike riding or brisk walking/jogging), Comparator: control group, open-skill (table tennis) Outcome: cardiorespiratory fitness, social participation, and BMI
-1
{"evidence_spans": [{"end": 35308, "start": 34796, "text": "nitive function, depression, and cardiorespiratory fitness) in relation to cognition and the tests of functional fitness also did not achieve significant difference in the three groups (all ps > 0.05) across the three groups at baseline. Paired t-tests showed ...
Background MEDLINE is the most widely used medical bibliographic database in the world. Most of its citations are in English and this can be an obstacle for some researchers to access the information the database contains. We created a multilingual query builder to facilitate access to the PubMed subset using a langua...
Intervention: English version of the query builder Comparator: French version of the query builder Outcome: perfect queries
-1
{"evidence_spans": [{"end": 1483, "start": 1354, "text": "lysed. There were significantly more perfect queries in the French group vs. the English group (respectively 37.9% vs. 17.9%; p\u2009<"}, {"end": 15364, "start": 15108, "text": "groups concerning over-specification errors, the use of incorrect operator or syntax...
Objective To compare the clinical pharmacokinetics of rocuronium when applied according to fat-free mass versus real body weight during anesthetic induction of patients with lymphedema. Methods Sixty patients with lymphedema (age, 18–60 years; American Society of Anesthesiologists physical status, I–II) undergoing...
Intervention: Group A (based on fat-free mass (FFM)) Comparator: Group B (based on real body weight (RBW)) Outcome: clinical duration of rocuronium
0
{"evidence_spans": [{"end": 7999, "start": 7912, "text": "ean\u2009\u00b1\u2009standard deviation.\r\nBMI: body mass index, FFM: fat-free mass.\r\n\r\nPatients in Gro"}, {"end": 8059, "start": 7912, "text": "ean\u2009\u00b1\u2009standard deviation.\r\nBMI: body mass index, FFM: fat-free mass.\r\n\r\nPatients in Group B...
Objective To compare the clinical pharmacokinetics of rocuronium when applied according to fat-free mass versus real body weight during anesthetic induction of patients with lymphedema. Methods Sixty patients with lymphedema (age, 18–60 years; American Society of Anesthesiologists physical status, I–II) undergoing...
Intervention: Group A (based on fat-free mass (FFM)) Comparator: Group B (based on real body weight (RBW)) Outcome: intubation condition as assessed by the Cooper score, in the first-pass intubation success rate
0
{"evidence_spans": [{"end": 8362, "start": 8185, "text": "n the T1, recovery index, and dosage between the two groups (P\u2009<\u20090.05). No significant difference was observed between the two groups in the intubation condition as assessed by "}, {"end": 8371, "start": 8185, "text": "n the T1, recovery index, and dos...
Background and Objectives This study evaluates the efficacy and safety of a sufentanil sublingual tablet system (SSTS) for the management of postoperative pain following open abdominal surgery. Methods At 13 hospital sites in the United States, patients following surgery with pain intensity of greater than 4 on an...
Intervention: sufentanil sublingual tablet system (SSTS) group Comparator: placebo group Outcome: Summed pain intensity difference over 48 hours
1
{"evidence_spans": [{"end": 1082, "start": 895, "text": "sults\r\nSummed pain intensity difference over 48 hours was significantly higher in the SSTS group than in the placebo group (least squares mean [SEM], 105.60 [10.14] vs 55.58 [13.11]; P = "}], "id": "13123", "pmcid": "4272222", "prompt_id": "13123", "split_group...
Background and Objectives This study evaluates the efficacy and safety of a sufentanil sublingual tablet system (SSTS) for the management of postoperative pain following open abdominal surgery. Methods At 13 hospital sites in the United States, patients following surgery with pain intensity of greater than 4 on an...
Intervention: sufentanil sublingual tablet system (SSTS) group Comparator: placebo group Outcome: Mean summed pain intensity difference (SPID) and total pain relief (TOTPAR) scores at all time points from 1 hour (SPID) or 2 hours (TOTPAR) until 72 hours
1
{"evidence_spans": [{"end": 1239, "start": 1083, "text": ".001). Mean SPID and TOTPAR scores were significantly higher in the SSTS group at all time points from 1 hour (SPID) or 2 hours (TOTPAR) until 72 hours (P <"}], "id": "13124", "pmcid": "4272222", "prompt_id": "13124", "split_group_id": "4272222", "votes": {"1": ...
Background and Objectives This study evaluates the efficacy and safety of a sufentanil sublingual tablet system (SSTS) for the management of postoperative pain following open abdominal surgery. Methods At 13 hospital sites in the United States, patients following surgery with pain intensity of greater than 4 on an...
Intervention: sufentanil sublingual tablet system (SSTS) group Comparator: placebo group Outcome: global assessment ratings of good or excellent
1
{"evidence_spans": [{"end": 1412, "start": 1239, "text": " 0.05). In the SSTS group, patient global assessment and health care provider global assessment ratings of good or excellent were greater than placebo at all time points (P "}, {"end": 1413, "start": 1240, "text": "0.05). In the SSTS group, patient global assess...
Background and Objectives This study evaluates the efficacy and safety of a sufentanil sublingual tablet system (SSTS) for the management of postoperative pain following open abdominal surgery. Methods At 13 hospital sites in the United States, patients following surgery with pain intensity of greater than 4 on an...
Intervention: sufentanil sublingual tablet system (SSTS) group Comparator: placebo group Outcome: Safety parameters, including adverse events and vital signs
0
{"evidence_spans": [{"end": 1509, "start": 1414, "text": "0.01). Safety parameters, including adverse events and vital signs, were similar for SSTS and p"}], "id": "13126", "pmcid": "4272222", "prompt_id": "13126", "split_group_id": "4272222", "votes": {"0": 2}}
Introduction: We have evaluated efficacy of diclofenac sodium as pre-emptive analgesia agent in a prospective triple blind placebo controlled randomized clinical trial in a patients undergoing third molar impaction surgery. Materials and Methods: Randomization of groups was done by randomization software and two g...
Intervention: diclofenac sodium pre operatively Comparator: placebo pre operatively Outcome: The mean scores of tenderness
-1
{"evidence_spans": [{"end": 829, "start": 704, "text": "scale. Collected data shows that there is a significant reduction in the score of postop tenderness in experimental group (P "}], "id": "13127", "pmcid": "3700147", "prompt_id": "13127", "split_group_id": "3700147", "votes": {"-1": 1}}
Introduction: We have evaluated efficacy of diclofenac sodium as pre-emptive analgesia agent in a prospective triple blind placebo controlled randomized clinical trial in a patients undergoing third molar impaction surgery. Materials and Methods: Randomization of groups was done by randomization software and two g...
Intervention: diclofenac sodium pre operatively Comparator: placebo pre operatively Outcome: the mean scores for 3 days post-operatively
-1
{"evidence_spans": [{"end": 8440, "start": 8261, "text": "vely, with P-value of 0.099 which is less significant; however, the mean scores for 3 days post-operatively for the experimental group and control group are 3.5 and 5.1, respectiv"}, {"end": 8440, "start": 8270, "text": "h P-value of 0.099 which is less signific...
Introduction: We have evaluated efficacy of diclofenac sodium as pre-emptive analgesia agent in a prospective triple blind placebo controlled randomized clinical trial in a patients undergoing third molar impaction surgery. Materials and Methods: Randomization of groups was done by randomization software and two g...
Intervention: diclofenac sodium pre operatively Comparator: placebo pre operatively Outcome: Score mean of tenderness on the 6th post-operative day
-1
{"evidence_spans": [{"end": 8621, "start": 8441, "text": "ly, with P-value of 0.001 which is highly significant. Score mean of tenderness on the 6th post-operative day for experimental group is 1.6 and for control group is 3.6 with P valu"}], "id": "13129", "pmcid": "3700147", "prompt_id": "13129", "split_group_id": "3...
Introduction: We have evaluated efficacy of diclofenac sodium as pre-emptive analgesia agent in a prospective triple blind placebo controlled randomized clinical trial in a patients undergoing third molar impaction surgery. Materials and Methods: Randomization of groups was done by randomization software and two g...
Intervention: diclofenac sodium pre operatively Comparator: placebo pre operatively Outcome: trismus mean score at 1-hour post-operatively
-1
{"evidence_spans": [{"end": 8789, "start": 8622, "text": " of 0.001 which shows a highly significant difference. And for trismus mean score at 1-hour post-operatively for experimental group is 0.36 and control group 0.66 with"}], "id": "13130", "pmcid": "3700147", "prompt_id": "13130", "split_group_id": "3700147", "vot...
Background Stroke causes lasting disability and the burden of stroke is expected to increase substantially during the next decades. Optimal rehabilitation is therefore mandatory. Early supported discharge (ESD) has previously shown beneficial, but all major studies were carried out more than ten years ago. We wanted t...
Intervention: Early supported discharge (ESD) 1 Comparator: ESD 2 Outcome: patients were independent
0
{"evidence_spans": [{"end": 1689, "start": 1423, "text": "ntrols. More patients in the pooled ESD groups were independent at 3 (p\u2009=\u20090.086) and 6\u00a0months (p\u2009=\u20090.122) compared to controls and there also was a significant difference in 3\u00a0month change score between them (p\u2009=\u20090.049). T...
Background Stroke causes lasting disability and the burden of stroke is expected to increase substantially during the next decades. Optimal rehabilitation is therefore mandatory. Early supported discharge (ESD) has previously shown beneficial, but all major studies were carried out more than ten years ago. We wanted t...
Intervention: Early supported discharge (ESD) 1 , ESD 2 Comparator: control Outcome: Patient satisfaction
0
{"evidence_spans": [{"end": 18063, "start": 17900, "text": " did not differ significantly at any point in time for mean values of the primary outcome mRS, nor for BI and NIHSS scores as well as all change scores (Table\u00a02). "}, {"end": 18064, "start": 17901, "text": "did not differ significantly at any point in tim...
Background Melatonin is often used as a sleeping aid in elderly adults. As previous studies suggest a protective role of melatonin against osteoporosis, it is important to document its safety. Treatment should not cause any hangover effect that could potentially lead to falls and fractures. We therefore aimed to evalu...
Intervention: 1 or 3&nbsp;mg melatonin Comparator: placebo Outcome: quality of sleep index (PSQI)
0
{"evidence_spans": [{"end": 19136, "start": 18917, "text": "\r\n4.31 (\u22129.61;22.58)\r\n\u2003Melatonin\r\n163 (138;182)\r\n\r\n0.99 (\u22122.53;9.66)\r\n*Significant changes between groups\r\n\r\nStratifying for doses of melatonin did not change the results in either balance- nor muscle function tests (da"}, {"end"...
Background Melatonin is often used as a sleeping aid in elderly adults. As previous studies suggest a protective role of melatonin against osteoporosis, it is important to document its safety. Treatment should not cause any hangover effect that could potentially lead to falls and fractures. We therefore aimed to evalu...
Intervention: 1 or 3 mg melatonin Comparator: placebo Outcome: poor quality sleep/insomnia
-1
{"evidence_spans": [{"end": 19404, "start": 19136, "text": "ta not shown).\r\nTable\u00a04 shows the results of the questionnaire data. According to quality of sleep index (PSQI), both groups had a good quality of sleep at baseline (5 in placebo group vs. 4.5 in melatonin group). No significant changes between groups w...
Background Melatonin is often used as a sleeping aid in elderly adults. As previous studies suggest a protective role of melatonin against osteoporosis, it is important to document its safety. Treatment should not cause any hangover effect that could potentially lead to falls and fractures. We therefore aimed to evalu...
Intervention: 1 or 3 mg melatonin Comparator: placebo Outcome: Heart rate and blood pressure
0
{"evidence_spans": [{"end": 22105, "start": 21800, "text": "\u00a04). A significant inverse correlation was present between changes in PCS and changes in PSQI (r\u2009=\u2009\u22120.36, p\u2009<\u20090.01) meaning that the better PCS, the better quality of sleep. No correlation was present between PSQI and other physic...
Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive ...
Intervention: Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) Comparator: placebo Outcome: the mean reduction of migraine days
1
{"evidence_spans": [{"end": 17333, "start": 17099, "text": "4 versus 95% CI, \u22123.97 to \u22120.90; P = 0.042).\r\nAnd there was significant difference in the proportion of patients with a reduction of migraine days by at least 50% between the CXDT-HFG group and the placebo group at follow-up period (8"}], "id": "13...
Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive ...
Intervention: Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) Comparator: placebo Outcome: proportion of patients with a reduction of migraine days by at least 50%
-1
{"evidence_spans": [{"end": 17333, "start": 17095, "text": "\u22122.34 versus 95% CI, \u22123.97 to \u22120.90; P = 0.042).\r\nAnd there was significant difference in the proportion of patients with a reduction of migraine days by at least 50% between the CXDT-HFG group and the placebo group at follow-up period (8"}], ...
Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive ...
Intervention: Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) Comparator: placebo Outcome: frequency of migraine attacks
-1
{"evidence_spans": [{"end": 866, "start": 704, "text": " Compared with the placebo group, the CXDT-HFG group showed significant reduction in migraine days and attacks frequency at week 12 and follow-up period (P < 0.05"}, {"end": 17712, "start": 17500, "text": "16 times and 3.91\u2009\u00b1\u20094.32 times in the place...
Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive ...
Intervention: Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) Comparator: placebo Outcome: attack frequency
-1
{"evidence_spans": [{"end": 866, "start": 704, "text": " Compared with the placebo group, the CXDT-HFG group showed significant reduction in migraine days and attacks frequency at week 12 and follow-up period (P < 0.05"}], "id": "13142", "pmcid": "3525331", "prompt_id": "13142", "split_group_id": "3525331", "votes": {"...
Objective. To evaluate the efficacy of traditional Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) for migraine patients with “the Syndrome of Liver Wind and Blood Stasis.” Methods. 150 migraine patients were recruited and assigned randomly in a double-blind, placebo-controlled study to receive ...
Intervention: Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) Comparator: placebo Outcome: The number of patients using acute pain drugs, such as aspirin, phenacetin, or ibuprofen, etc.
0
{"evidence_spans": [{"end": 1156, "start": 1058, "text": " there were no significant differences between the two groups in analgesics consumption (P > 0.05)"}, {"end": 18906, "start": 18694, "text": "13) (Table 2; Figures 5 and 6). \r\n\r\n3.6. Acute Medication\r\nThe number of patients using acute pain drugs, such as ...
Introduction In phase-3 clinical trials, the interleukin (IL-1) blocker, rilonacept (IL-1 Trap), demonstrated efficacy for gout flare prevention during initiation of urate-lowering therapy. This trial evaluated rilonacept added to a standard-of-care, indomethacin, for treatment of acute gout flares. Methods Adults...
Intervention: subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; Comparator: SC placebo at baseline plus oral indomethacin as above Outcome: change in pain in the index joint
0
{"evidence_spans": [{"end": 1798, "start": 1522, "text": "0001). Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 \u00b1 0.92) relative to indomethacin alone (-1.40 \u00b1 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monoth...
Introduction In phase-3 clinical trials, the interleukin (IL-1) blocker, rilonacept (IL-1 Trap), demonstrated efficacy for gout flare prevention during initiation of urate-lowering therapy. This trial evaluated rilonacept added to a standard-of-care, indomethacin, for treatment of acute gout flares. Methods Adults...
Intervention: subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; Comparator: SC placebo at baseline plus oral indomethacin as above Outcome: Pain reduction
0
{"evidence_spans": [{"end": 1971, "start": 1799, "text": "ormed. Pain reduction over the 72-hour period with rilonacept alone (-0.69 \u00b1 0.97) was less than that in the other groups, but pain reduction was similar among groups at 72"}, {"end": 17976, "start": 17530, "text": "0 = no pain to 4 = extreme pain), and (B)...
Introduction In phase-3 clinical trials, the interleukin (IL-1) blocker, rilonacept (IL-1 Trap), demonstrated efficacy for gout flare prevention during initiation of urate-lowering therapy. This trial evaluated rilonacept added to a standard-of-care, indomethacin, for treatment of acute gout flares. Methods Adults...
Intervention: SC rilonacept 320 mg at baseline plus oral placebo Comparator: SC placebo at baseline plus oral indomethacin as above Outcome: Pain reduction according to the numerical rating scale (NRS)
-1
{"evidence_spans": [{"end": 17187, "start": 16646, "text": "d that the difference between indomethacin monotherapy and rilonacept monotherapy significantly favored indomethacin (P < 0.0001). Similar results were observed with the NRS; significant reductions from baseline were observed in each of the treatment groups (P...
Introduction In phase-3 clinical trials, the interleukin (IL-1) blocker, rilonacept (IL-1 Trap), demonstrated efficacy for gout flare prevention during initiation of urate-lowering therapy. This trial evaluated rilonacept added to a standard-of-care, indomethacin, for treatment of acute gout flares. Methods Adults...
Intervention: subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days Comparator: SC rilonacept 320 mg at baseline plus oral placebo Outcome: high sensitivity C-reactive protein (hs-CRP)
-1
{"evidence_spans": [], "id": "13147", "pmcid": "3672764", "prompt_id": "13147", "split_group_id": "3672764", "votes": {"-1": 1}}
Purpose The WEI Jet Endotracheal Tube (WEI JET) is a new tracheal tube that facilitates both oxygenation and ventilation during the process of intubation and assists tracheal intubation in patients with difficult airway. We evaluated the effectiveness and usefulness of the WEI JET in combination with lightwand under d...
Intervention: lightwand only; lightwand under direct laryngoscopy; Comparator: lightwand with WEI JET under direct laryngoscopy Outcome: the intubation time
-1
{"evidence_spans": [{"end": 1165, "start": 1005, "text": ".000). The intubation time was significantly longer in the WEI group (110.8\u00b118.3 s) than in the LW group (63.3\u00b127.5 s, p = 0.000) and DL group (66.7\u00b129.4 s, p ="}, {"end": 13856, "start": 13690, "text": "o attempts.\r\nSignificant comparisons are ...
Purpose The WEI Jet Endotracheal Tube (WEI JET) is a new tracheal tube that facilitates both oxygenation and ventilation during the process of intubation and assists tracheal intubation in patients with difficult airway. We evaluated the effectiveness and usefulness of the WEI JET in combination with lightwand under d...
Intervention: lightwand only; Comparator: lightwand with WEI JET under direct laryngoscopy Outcome: successful tracheal intubation attempts
1
{"evidence_spans": [{"end": 14067, "start": 13936, "text": "(110.8\u00b118.3 s) than the LW group (63.3\u00b127.5 s, p = 0.000) or DL group (66.7\u00b129.4 s, p = 0.000), the lowest SpO2 in WEI group was si"}], "id": "13149", "pmcid": "4372550", "prompt_id": "13149", "split_group_id": "4372550", "votes": {"1": 1}}
Purpose The WEI Jet Endotracheal Tube (WEI JET) is a new tracheal tube that facilitates both oxygenation and ventilation during the process of intubation and assists tracheal intubation in patients with difficult airway. We evaluated the effectiveness and usefulness of the WEI JET in combination with lightwand under d...
Intervention: lightwand only; Comparator: lightwand under direct laryngoscopy; Outcome: successful tracheal intubation attempts
0
{"evidence_spans": [{"end": 14195, "start": 13936, "text": "(110.8\u00b118.3 s) than the LW group (63.3\u00b127.5 s, p = 0.000) or DL group (66.7\u00b129.4 s, p = 0.000), the lowest SpO2 in WEI group was significantly higher than other two groups. The WEI JET significantly reduced successful tracheal intubation attempt...
Background: Attention deficit-hyperactivity disorder (ADHD) is the most common neuro-developmental disorder in childhood. Its pharmacologic treatment mostly includes methylphenidate, yet many parents seek alternative, “natural,” therapeutic options, commonly omega-3 fatty acids. Previous studies of supplementation with...
Intervention: alpha-linolenic acid (ALA), a medium-chained, plant-based omega-3 fatty acid (18:3) Comparator: placebo Outcome: ADHD symptoms and a computerized continuous performance functions test.
0
{"evidence_spans": [{"end": 1294, "start": 1163, "text": ". No significant difference was found in any of the measured variables tested before and after supplementation, in both study group"}, {"end": 1416, "start": 1294, "text": "s. No between-group difference was found in the changes of the various measures of ADHD s...
Background The relapse rate of ulcerative colitis (UC) is high. The efficacy of combined diosmectite and mesalazine treatment for active mild-to-moderate UC was investigated. Material/Methods A total of 120 patients with UC were enrolled in this randomized, single-blind, placebo-controlled study. Sixty patients we...
Intervention: Diosmectite group (diosmectite and mesalazine) Comparator: Placebo group (placebo and mesalazine) Outcome: clinical responses
0
{"evidence_spans": [{"end": 13084, "start": 12813, "text": " 2.0\u00b11.3 times per day (P<0.05) (Table 3). There was no significant difference in clinical responses between the Diosmectite group and the Placebo group (P>0.05). However, rates of clinical remission and endoscopic mucosal healing were significantly highe...
Background The relapse rate of ulcerative colitis (UC) is high. The efficacy of combined diosmectite and mesalazine treatment for active mild-to-moderate UC was investigated. Material/Methods A total of 120 patients with UC were enrolled in this randomized, single-blind, placebo-controlled study. Sixty patients we...
Intervention: Diosmectite group (diosmectite and mesalazine) Comparator: Placebo group (placebo and mesalazine) Outcome: The defecation frequency
0
{"evidence_spans": [{"end": 1512, "start": 1452, "text": "group. Defecation frequency was lower, but this was not sign"}, {"end": 14024, "start": 13889, "text": "group (P=0.028 and P=0.028, respectively). The defecation frequency of the Diosmectite group was lower than in the Placebo group, but t"}], "id": "13157", "pm...
Purpose Prior results from the registration system oncological gynecology (ROGY) care trial showed that survivorship care plans (SCPs) increased threatening illness perceptions in gynecological cancer survivors, but it remained unclear whether this would result in poorer physical and psychosocial outcomes. The aim of ...
Intervention: survivorship care plans (SCPs) Comparator: ‘usual care.’ Outcome: experienced symptoms, concerns about the illness
1
{"evidence_spans": [{"end": 20609, "start": 20403, "text": "ed/living together; no partner\u2009divorced/widowed/never married. The numbers may not always add up to 100, because percentages have been rounded off to whole numbers\r\n\r\n\r\nFigure\u00a01 shows the differences in ill"}], "id": "13158", "pmcid": "5951872"...
Purpose Prior results from the registration system oncological gynecology (ROGY) care trial showed that survivorship care plans (SCPs) increased threatening illness perceptions in gynecological cancer survivors, but it remained unclear whether this would result in poorer physical and psychosocial outcomes. The aim of ...
Intervention: survivorship care plans (SCPs) Comparator: ‘usual care.’ Outcome: emotional impact of the disease
0
{"evidence_spans": [{"end": 20750, "start": 20610, "text": "ess perceptions between the SCP care and usual care arms. Significantly more endometrial patients in the SCP care arm compared to the usual "}, {"end": 20856, "start": 20610, "text": "ess perceptions between the SCP care and usual care arms. Significantly more...
Purpose Prior results from the registration system oncological gynecology (ROGY) care trial showed that survivorship care plans (SCPs) increased threatening illness perceptions in gynecological cancer survivors, but it remained unclear whether this would result in poorer physical and psychosocial outcomes. The aim of ...
Intervention: survivorship care plans (SCPs) Comparator: ‘usual care.’ Outcome: trust that the treatment would help to cure the illness
0
{"evidence_spans": [{"end": 20856, "start": 20610, "text": "ess perceptions between the SCP care and usual care arms. Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p\u2009=\u20090.02) and high concerns about the illness (16%"}, ...
Objective: The objective of the study was to compare and evaluate the clinical and radiographic outcome of single- versus multivisit endodontic treatment in teeth with periapical pathology at the end of 1, 3, and 6 months. Materials and Methods: Sixty single- and multi-rooted teeth indicated for root canal treatme...
Intervention: Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer Comparator: Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used Ou...
0
{"evidence_spans": [{"end": 9478, "start": 9171, "text": " the radiographic evaluation using PAI scoring system.\r\nWhen scores obtained by radiographic evaluation were submitted to Kruskal\u2013Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, ...
Objective: The objective of the study was to compare and evaluate the clinical and radiographic outcome of single- versus multivisit endodontic treatment in teeth with periapical pathology at the end of 1, 3, and 6 months. Materials and Methods: Sixty single- and multi-rooted teeth indicated for root canal treatme...
Intervention: Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer Comparator: Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used Ou...
0
{"evidence_spans": [{"end": 9479, "start": 9258, "text": "aphic evaluation were submitted to Kruskal\u2013Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluatio"}], "id": "13162", "pmcid": "579999...
Background Novel feline RBC antigens might contribute to decreased efficacy of RBC transfusion and increased incidence of acute transfusion reactions (ATR). Objectives To examine the effect of major cross‐match in transfusion‐naïve anemic cats on the incidence of acute immunologic transfusion reaction and transfus...
Intervention: received cross‐match and blood type compatible pRBCs Comparator: noncross‐matched blood type compatible pRBCs Outcome: incidence of transfusion reactions
0
{"evidence_spans": [{"end": 1018, "start": 864, "text": "\r\n\r\nResults\r\nNo significant difference in incidence of transfusion reactions between cross\u2010matched and noncross\u2010matched groups (CM+ 4/24; 17%, CM\u2013 7/24; 2"}], "id": "13167", "pmcid": "5980435", "prompt_id": "13167", "split_group_id": "5980435...
Background Novel feline RBC antigens might contribute to decreased efficacy of RBC transfusion and increased incidence of acute transfusion reactions (ATR). Objectives To examine the effect of major cross‐match in transfusion‐naïve anemic cats on the incidence of acute immunologic transfusion reaction and transfus...
Intervention: received cross‐match and blood type compatible pRBCs Comparator: noncross‐matched blood type compatible pRBCs Outcome: packed cell volume
0
{"evidence_spans": [{"end": 1385, "start": 1019, "text": "%, P\u2009=\u2009.16). No significant difference between groups in mean change in PCV after transfusion scaled to dose of pRBCs administered at any time point after transfusion (immediate: CM+ 0.62\u2009\u00b1\u20090.59, CM\u2013 0.75\u2009\u00b1\u20090.48, P\u2...
Purpose: To compare visual acuity improvement between continuous and split part-time occlusion for the treatment of moderate and severe anisometropic amblyopia. Methods: Randomised clinical trials in 6 – 13 y.o children with moderate and severe anisometropic amblyopia. Each patient was consecutively selected with ...
Intervention: continuous occlusion Comparator: split part-time occlusion Outcome: visual acuity’s improvement
0
{"evidence_spans": [{"end": 654, "start": 512, "text": "ults:\r\nBest corrected visual acuity\u2019s improvement was comparable between continuous and split part-time occlusion (0.20\u00b10.27 vs 0.21\u00b10.25; p ="}], "id": "13169", "pmcid": "5827295", "prompt_id": "13169", "split_group_id": "5827295", "votes": {"0":...
BACKGROUND Obesity is associated with poorly differentiated and advanced prostate cancer and increased mortality. In preclinical models, caloric restriction delays prostate cancer progression and prolongs survival. We sought to determine if weight loss (WL) in men with prostate cancer prior to radical prostatectomy af...
Intervention: WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity Comparator: control group Outcome: weight loss
1
{"evidence_spans": [{"end": 1351, "start": 1231, "text": "group. Subjects in the intervention group had significantly more weight loss (WL:\u22123.7 \u00b1 0.5 kg; Control:\u22121.6 \u00b1 0.5 kg; p"}, {"end": 1374, "start": 1231, "text": "group. Subjects in the intervention group had significantly more weight loss (WL...
BACKGROUND Obesity is associated with poorly differentiated and advanced prostate cancer and increased mortality. In preclinical models, caloric restriction delays prostate cancer progression and prolongs survival. We sought to determine if weight loss (WL) in men with prostate cancer prior to radical prostatectomy af...
Intervention: WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity Comparator: control group Outcome: total fat mass
-1
{"evidence_spans": [{"end": 1465, "start": 1231, "text": "group. Subjects in the intervention group had significantly more weight loss (WL:\u22123.7 \u00b1 0.5 kg; Control:\u22121.6 \u00b1 0.5 kg; p=0.007) than the control group and total fat mass was significantly reduced (WL:\u22122.1 \u00b1 0.4; Control: 0.1 \u00b1 ...
BACKGROUND Obesity is associated with poorly differentiated and advanced prostate cancer and increased mortality. In preclinical models, caloric restriction delays prostate cancer progression and prolongs survival. We sought to determine if weight loss (WL) in men with prostate cancer prior to radical prostatectomy af...
Intervention: WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity Comparator: control group Outcome: apoptotic or proliferation index
0
{"evidence_spans": [{"end": 1557, "start": 1466, "text": ".015). There was no significant difference in apoptotic or proliferation index between the "}], "id": "13173", "pmcid": "5986584", "prompt_id": "13173", "split_group_id": "5986584", "votes": {"0": 2}}
BACKGROUND Obesity is associated with poorly differentiated and advanced prostate cancer and increased mortality. In preclinical models, caloric restriction delays prostate cancer progression and prolongs survival. We sought to determine if weight loss (WL) in men with prostate cancer prior to radical prostatectomy af...
Intervention: WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity Comparator: control group Outcome: triglyceride and insulin level
-1
{"evidence_spans": [{"end": 1687, "start": 1558, "text": "roups. Among the other biomarkers, triglyceride and insulin levels were significantly decreased in the WL compared to the control"}], "id": "13174", "pmcid": "5986584", "prompt_id": "13174", "split_group_id": "5986584", "votes": {"-1": 2}}
Background: Minor oral surgical procedures are the most commonly performed procedures by oral and maxillofacial surgeons. Performance of painless surgical procedure is highly appreciated by the patients and is possible through the use of local anesthesia, conscious sedation or general anesthesia. Postoperative pain ca...
Intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I Comparator: mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II Outcome: mean volume of both the solutions used
0
{"evidence_spans": [{"end": 9957, "start": 9602, "text": " the minimum volume of anesthetic solution used was 4 ml. However, the mean volume of bupivacaine solution including the amount needed for infiltration/reanesthesia was slightly higher (4.15 \u00b1 0.52 ml) than the mean volume of buprenorphine combination with ...
Background: Minor oral surgical procedures are the most commonly performed procedures by oral and maxillofacial surgeons. Performance of painless surgical procedure is highly appreciated by the patients and is possible through the use of local anesthesia, conscious sedation or general anesthesia. Postoperative pain ca...
Intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I Comparator: mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II Outcome: subjective and objective onset of action
0
{"evidence_spans": [{"end": 1557, "start": 1469, "text": "lets). There was no significant difference between the two groups regarding the onset of"}, {"end": 10423, "start": 10276, "text": " group and 7.28 \u00b1 1.59 min in bupivacaine group [Table 1]. Statistically, no significant difference was observed between both...
Background: Minor oral surgical procedures are the most commonly performed procedures by oral and maxillofacial surgeons. Performance of painless surgical procedure is highly appreciated by the patients and is possible through the use of local anesthesia, conscious sedation or general anesthesia. Postoperative pain ca...
Intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I Comparator: mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II Outcome: duration of surgical procedure
0
{"evidence_spans": [{"end": 1610, "start": 1469, "text": "lets). There was no significant difference between the two groups regarding the onset of action of the anesthetic effect and duration of anes"}, {"end": 10556, "start": 10461, "text": "of action (P = 0.81).\r\nTable 1Evaluation of onset of action\r\nSimilarly, t...
Background: Minor oral surgical procedures are the most commonly performed procedures by oral and maxillofacial surgeons. Performance of painless surgical procedure is highly appreciated by the patients and is possible through the use of local anesthesia, conscious sedation or general anesthesia. Postoperative pain ca...
Intervention: 0.5% bupivacaine with 1:200000 epinephrine in group I Comparator: mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II Outcome: number of analgesic tablets
1
{"evidence_spans": [{"end": 11500, "start": 11082, "text": " anesthesia, postoperative analgesia, and duration of surgery\r\nOn comparing the total amount of analgesic medication ingested during the postoperative period, the mean dose of analgesic medication in bupivacaine group (1.64 \u00b1 0.99 tablets) was observed ...
Background It is important that response rates to postal surveys are as high as possible to ensure that the results are representative and to maximise statistical power. Previous research has suggested that any personalisation of approach helps to improve the response rate. This experiment tested whether personalising...
Intervention: covering letter with either a computer printed signature Comparator: covering letter a hand written signature Outcome: time to response
0
{"evidence_spans": [{"end": 6122, "start": 5969, "text": "uartile range 9 to 49 days). Kaplan-Meier survival analysis was performed on time to response and no difference between the groups was detected (Log rank"}, {"end": 6653, "start": 6438, "text": "control groups of 4% or larger. The results indicate that a hand-si...
Abstract Objectives: To evaluate the short-term efficacy and safety of desvenlafaxine (25–50 mg/d) compared with placebo in children and adolescents with major depressive disorder (MDD). Methods: Outpatient children (7–11 years) and adolescents (12–17 years) who met DSM-IV-TR criteria for MDD and had screening and ba...
Intervention: fluoxetine Comparator: placebo Outcome: CGI-I response rate
1
{"evidence_spans": [{"end": 21471, "start": 21346, "text": "RS-R, Children's Depression Rating Scale\u2013Revised; CI, confidence interval; ITT, intent-to-treat; MMRM, mixed-effects model fo"}], "id": "13181", "pmcid": "5771543", "prompt_id": "13181", "split_group_id": "5771543", "votes": {"1": 2}}
Abstract Objectives: To evaluate the short-term efficacy and safety of desvenlafaxine (25–50 mg/d) compared with placebo in children and adolescents with major depressive disorder (MDD). Methods: Outpatient children (7–11 years) and adolescents (12–17 years) who met DSM-IV-TR criteria for MDD and had screening and ba...
Intervention: desvenlafaxine Comparator: placebo Outcome: CGI-I response rate
0
{"evidence_spans": [{"end": 21632, "start": 21471, "text": "r repeated measures; SE, standard error.\r\nAt week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p\u2009=\u20090"}, {"end": 21633, "start": 21472, "text": " repeated measures; SE, standard error.\r\n...
Abstract Objectives: To evaluate the short-term efficacy and safety of desvenlafaxine (25–50 mg/d) compared with placebo in children and adolescents with major depressive disorder (MDD). Methods: Outpatient children (7–11 years) and adolescents (12–17 years) who met DSM-IV-TR criteria for MDD and had screening and ba...
Intervention: desvenlafaxine, fluoxetine Comparator: placebo Outcome: Treatment-emergent adverse events (TEAEs)
0
{"evidence_spans": [{"end": 25189, "start": 24991, "text": "rse events\r\nTreatment-emergent adverse events (TEAEs) reported by more than 10% of patients in any group were headache, upper abdominal pain, and nausea. Table 3 shows the most frequent (\u22655% in any "}, {"end": 25215, "start": 24991, "text": "rse events\...
Introduction Antimalarial resistance has led to a global policy of artemisinin-based combination therapy. Despite growing resistance chloroquine (CQ) remained until recently the official first-line treatment for falciparum malaria in Pakistan, with sulfadoxine-pyrimethamine (SP) second-line. Co-treatment with the game...
Intervention: CQ+(3 d)AS; Comparator: SP+(3 d)AS Outcome: gametocytaemia
-1
{"evidence_spans": [{"end": 33551, "start": 33419, "text": "\n23/30 (76.7%) a, 1\r\n\r\nSP+AS\r\n5/7 (71.4%) b, 1\r\n\r\n5/37 (13.5) b, 2\r\n\r\nChloroquine or SP treatments in the same column that share the"}], "id": "13184", "pmcid": "3269419", "prompt_id": "13184", "split_group_id": "3269419", "votes": {"-1": 1}}
Background Despite the large body of literature demonstrating the effectiveness of cognitive behavioral treatments for agoraphobia, many patients remain untreated because of various barriers to treatment. Web-based and mobile-based interventions targeting agoraphobia may provide a solution to this problem, but there i...
Intervention: mobile app designed to target agoraphobia (called Agoraphobia Free) Comparator: mobile app designed to help with symptoms of anxiety in general (called Stress Free). Outcome: symptom severity over time
0
{"evidence_spans": [{"end": 1549, "start": 1209, "text": "\nResults\r\nBoth groups had statistically significant improvements in symptom severity over time (difference \u20135.97, 95% CI \u20138.49 to \u20133.44, P<.001 for Agoraphobia Free and \u20136.35, 95% CI \u20138.82 to \u20133.87, P<.001 for Stress Free), but t...